A phase II double-blind, placebo-controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics
| Image |  |
|---|---|
| Description | scholarly article by Marwan Sabbagh et al published July 2013 in Alzheimer's and Dementia |
| Author/s |
author: Michael Malek-Ahmadi |
| Publication date | July 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |